Protein Interactions & Misfolding Summary

Ubiquitous & Essential for:

  • Gene regulation

  • Cell signaling

  • Enzyme function

  • Structural integrity

  • Each eukaryotic protein: ~6–8 partners

  • Can be transient or stable, location-dependent

Examples

  • Haemoglobin – cooperative O₂ binding

  • Chaperones (GroEL/GroES) – prevent misfolding

  • ATP Synthase – rotating complex, energy production

  • Signalling – G-proteins, insulin receptors

  • Transcription regulators – form large complexes


🤝 Types of Protein Interactions

  1. Extensive surface contacts

  2. Linear motifs (short unstructured peptides)

  3. Modular domains (e.g., fibronectin)

Forces involved:

  • Hydrophobic burial

  • H-bonding

  • Salt bridges (ionic)

  • Shape & charge complementarity


Protein Aggregation

  • Edge β-strands: prone to form unwanted interactions

    • β-strand addition = β from one protein adds to sheet of another

  • Fibronectin example: exploited by S. aureus

Natural Protection Mechanisms

  • Fold protection (e.g. β-barrels)

  • Loops shielding strand edges

  • β-bulges – distort sheet, disrupt interaction

  • Proline/Trp residues – induce kinks

  • Charged residues – repel interaction

  • Short β-strands – limit aggregation


🧠 Protein Misfolding Diseases (Prion Diseases)

Key Diseases:

  • CJD – human, sporadic/inherited/acquired

  • vCJD – from BSE (mad cow)

  • Scrapie – sheep/goats

  • CWD – deer

  • Kuru – cannibalism (PNG)

  • GSS, Fatal Familial Insomnia – inherited

Key Points:

  • PrP (Prion Protein) causes disease via misfolding

    • PrPᶜ: normal, α-helical, monomeric

    • PrPˢᶜ: misfolded, β-sheet rich, aggregates

    • Resistant to proteinase K, seeds further misfolding

  • Infectious even without nucleic acids

    • Supports "Protein Only Hypothesis"


🔁 Conversion Models

  1. Nucleation model

    • Oligomers act as seeds for aggregation

  2. Template-assisted model

    • PrPᶜ binds PrPˢᶜ → refolds into PrPˢᶜ

Species Barrier

  • PrP must match host's sequence to propagate

  • Explains limited cross-species infection


🧪 Structure of PrP

  • N-terminal: disordered, Cu²⁺ binding (octapeptide repeats)

  • C-terminal: structured, α/β fold

    • Mutations here linked to disease (e.g., E200K, Q212P)

  • Attached to membrane via GPI anchor


🧱 Amyloids

  • Protein aggregates, 80–100 Å, fibrous, insoluble

  • Form cross-β sheets: parallel β-sheets in-register

    • Stabilized by steric zippers (hydrophobic interface)

    • Self-seeding, polymorphic

Diagnostic:

  • Congo red birefringence, X-ray diffraction


🧠 Alzheimer’s Disease

  • Caused by Aβ peptide (40–42 aa)

  • Derived from AβPP, forms amyloid fibrils

  • Protofilaments → plaques near neurons

  • Common fibril structure despite varied protein sources


🏞 Protein Folding Landscape

  • Funnel-like energy landscape

  • Aggregation occurs due to intermolecular contacts

  • Misfolding traps protein in aggregation-prone states


🧬 Summary

Concept

Key Detail

Normal PrP

Soluble, α-helical, monomer, GPI-anchored

Misfolded PrPSc

β-sheet, oligomeric, protease-resistant, pathogenic

Prion transmission

Protein-only, no nucleic acids

Amyloid

Cross-β, insoluble, fibrillar

Prevention of misfolding

β-bulges, loops, charged residues

Related diseases

CJD, vCJD, Alzheimer’s, Kuru, GSS